Maze Therapeutics, Inc.
General ticker "MAZE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.5B (TTM average)
Maze Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 2.2%: low 31.09$, high 32.48$
Factors to consider:
- Earnings expected soon, date: 2026-11-05 amc
- Total employees count: 141 (+12.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Clinical trial failure, Limited operating history, Need additional capital, Regulatory and compliance, Third-party risks
Short-term MAZE quotes
Long-term MAZE plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $167.50MM | $0.00MM |
| Operating Expenses | $98.55MM | $109.91MM | $142.90MM |
| Operating Income | $-98.55MM | $57.59MM | $-142.90MM |
| Non-Operating Income | $-1.86MM | $-4.18MM | $11.78MM |
| R&D Expense | $73.94MM | $83.50MM | $108.45MM |
| Income(Loss) | $-100.42MM | $53.40MM | $-131.12MM |
| Taxes | $0.00MM | $1.17MM | $0.00MM |
| Net Income(Loss)* | $-100.42MM | $52.23MM | $-131.12MM |
| Stockholders Equity | $10.05MM | $-311.18MM | $354.97MM |
| Assets | $71.50MM | $240.54MM | $397.13MM |
| Operating Cash Flow | $-86.83MM | $75.95MM | $-111.94MM |
| Capital expenditure | $0.44MM | $1.15MM | $0.79MM |
| Investing Cash Flow | $-0.44MM | $-1.15MM | $-170.96MM |
| Financing Cash Flow | $16.39MM | $92.85MM | $275.34MM |
| Earnings Per Share** | $-2.29 | $1.19 | $-3.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.